Global Influenza Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 17-May-2019
No. of pages: 120
Inquire Before Buying

Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza.

The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.

The global Influenza Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Influenza Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Influenza Vaccine in these regions.

This research report categorizes the global Influenza Vaccine market by top players/brands, region, type and end user. This report also studies the global Influenza Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- AstraZeneca

- CSL

- GlaxoSmithKline

- Sanofi

- Altimmune

- BionVax

- FluGen

- Folia Biotech

- Genentech

- Green Cross

- Medicago

- Moderna Therapeutics

- Novavax

- Shijiazhuang Yiling Pharmaceutical

- SK Chemicals

- UNM Pharma

- Vaccitec

Market size by Product

- Fluzone/Vaxigrip

- FluMist

- Fluarix and Flulaval

- Anflu

- Fluvax/Afluria

- Flucelvax and Fluvirin

Market size by End User

- Adults

- Pediatrics

- Senior Citizens

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Influenza Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Influenza Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Influenza Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Influenza Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Influenza Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Influenza Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Influenza Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Influenza Vaccine Market Size Growth Rate by Product
1.4.2 Fluzone/Vaxigrip
1.4.3 FluMist
1.4.4 Fluarix and Flulaval
1.4.5 Anflu
1.4.6 Fluvax/Afluria
1.4.7 Flucelvax and Fluvirin
1.5 Market by End User
1.5.1 Global Influenza Vaccine Market Size Growth Rate by End User
1.5.2 Adults
1.5.3 Pediatrics
1.5.4 Senior Citizens
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Market Size
2.1.1 Global Influenza Vaccine Revenue 2014-2025
2.1.2 Global Influenza Vaccine Sales 2014-2025
2.2 Influenza Vaccine Growth Rate by Regions
2.2.1 Global Influenza Vaccine Sales by Regions
2.2.2 Global Influenza Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Influenza Vaccine Sales by Manufacturers
3.1.1 Influenza Vaccine Sales by Manufacturers
3.1.2 Influenza Vaccine Sales Market Share by Manufacturers
3.1.3 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Influenza Vaccine Revenue by Manufacturers
3.2.1 Influenza Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Influenza Vaccine Price by Manufacturers
3.4 Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Influenza Vaccine Sales by Product
4.2 Global Influenza Vaccine Revenue by Product
4.3 Influenza Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Influenza Vaccine Breakdown Data by End User
6 North America
6.1 North America Influenza Vaccine by Countries
6.1.1 North America Influenza Vaccine Sales by Countries
6.1.2 North America Influenza Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Influenza Vaccine by Product
6.3 North America Influenza Vaccine by End User
7 Europe
7.1 Europe Influenza Vaccine by Countries
7.1.1 Europe Influenza Vaccine Sales by Countries
7.1.2 Europe Influenza Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Vaccine by Product
7.3 Europe Influenza Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccine by Countries
8.1.1 Asia Pacific Influenza Vaccine Sales by Countries
8.1.2 Asia Pacific Influenza Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Influenza Vaccine by Product
8.3 Asia Pacific Influenza Vaccine by End User
9 Central & South America
9.1 Central & South America Influenza Vaccine by Countries
9.1.1 Central & South America Influenza Vaccine Sales by Countries
9.1.2 Central & South America Influenza Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Influenza Vaccine by Product
9.3 Central & South America Influenza Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Influenza Vaccine by Countries
10.1.1 Middle East and Africa Influenza Vaccine Sales by Countries
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Influenza Vaccine by Product
10.3 Middle East and Africa Influenza Vaccine by End User
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Influenza Vaccine Products Offered
11.1.5 AstraZeneca Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 Company Business Overview
11.2.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 CSL Influenza Vaccine Products Offered
11.2.5 CSL Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Business Overview
11.3.3 GlaxoSmithKline Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GlaxoSmithKline Influenza Vaccine Products Offered
11.3.5 GlaxoSmithKline Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Influenza Vaccine Products Offered
11.4.5 Sanofi Recent Development
11.5 Altimmune
11.5.1 Altimmune Company Details
11.5.2 Company Business Overview
11.5.3 Altimmune Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Altimmune Influenza Vaccine Products Offered
11.5.5 Altimmune Recent Development
11.6 BionVax
11.6.1 BionVax Company Details
11.6.2 Company Business Overview
11.6.3 BionVax Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 BionVax Influenza Vaccine Products Offered
11.6.5 BionVax Recent Development
11.7 FluGen
11.7.1 FluGen Company Details
11.7.2 Company Business Overview
11.7.3 FluGen Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 FluGen Influenza Vaccine Products Offered
11.7.5 FluGen Recent Development
11.8 Folia Biotech
11.8.1 Folia Biotech Company Details
11.8.2 Company Business Overview
11.8.3 Folia Biotech Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Folia Biotech Influenza Vaccine Products Offered
11.8.5 Folia Biotech Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Company Business Overview
11.9.3 Genentech Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Genentech Influenza Vaccine Products Offered
11.9.5 Genentech Recent Development
11.10 Green Cross
11.10.1 Green Cross Company Details
11.10.2 Company Business Overview
11.10.3 Green Cross Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Green Cross Influenza Vaccine Products Offered
11.10.5 Green Cross Recent Development
11.11 Medicago
11.12 Moderna Therapeutics
11.13 Novavax
11.14 Shijiazhuang Yiling Pharmaceutical
11.15 SK Chemicals
11.16 UNM Pharma
11.17 Vaccitec
12 Future Forecast
12.1 Influenza Vaccine Market Forecast by Regions
12.1.1 Global Influenza Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Influenza Vaccine Revenue Forecast by Regions 2019-2025
12.2 Influenza Vaccine Market Forecast by Product
12.2.1 Global Influenza Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Influenza Vaccine Revenue Forecast by Product 2019-2025
12.3 Influenza Vaccine Market Forecast by End User
12.4 North America Influenza Vaccine Forecast
12.5 Europe Influenza Vaccine Forecast
12.6 Asia Pacific Influenza Vaccine Forecast
12.7 Central & South America Influenza Vaccine Forecast
12.8 Middle East and Africa Influenza Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Influenza Vaccine Product Picture
Table Influenza Vaccine Market Segments
Table Key Manufacturers Influenza Vaccine Covered
Table Global Influenza Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Influenza Vaccine Sales Market Share by Product 2014-2025
Figure Fluzone/Vaxigrip Product Picture
Table Major Manufacturers of Fluzone/Vaxigrip
Figure FluMist Product Picture
Table Major Manufacturers of FluMist
Figure Fluarix and Flulaval Product Picture
Table Major Manufacturers of Fluarix and Flulaval
Figure Anflu Product Picture
Table Major Manufacturers of Anflu
Figure Fluvax/Afluria Product Picture
Table Major Manufacturers of Fluvax/Afluria
Figure Flucelvax and Fluvirin Product Picture
Table Major Manufacturers of Flucelvax and Fluvirin
Table Global Influenza Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Adults
Figure Pediatrics
Figure Senior Citizens
Figure Influenza Vaccine Report Years Considered
Figure Global Influenza Vaccine Market Size 2014-2025 (Million US$)
Figure Global Influenza Vaccine Sales 2014-2025 (K Units)
Table Global Influenza Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Influenza Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure Global Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Influenza Vaccine Sales Market Share by Regions
Table Global Influenza Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Influenza Vaccine Revenue Market Share by Regions
Table Global Influenza Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Influenza Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Influenza Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Influenza Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Influenza Vaccine Price (2014-2019) (USD/Unit)
Table Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Influenza Vaccine Product Type
Table Date of International Manufacturers Enter into Influenza Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Influenza Vaccine Sales by Product (2014-2019) (K Units)
Table Global Influenza Vaccine Sales Share by Product (2014-2019)
Figure Global Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure Global Influenza Vaccine Sales Market Share by Product in 2018
Table Global Influenza Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Influenza Vaccine Revenue Share by Product (2014-2019)
Figure Global Influenza Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Influenza Vaccine Revenue Market Share by Product in 2018
Table Influenza Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Influenza Vaccine Sales by End User (2014-2019) (K Units)
Table Global Influenza Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Influenza Vaccine Market Share by End User (2014-2019)
Figure Global Sales Influenza Vaccine Market Share by End User in 2018
Figure North America Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Influenza Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Influenza Vaccine Sales Market Share by Countries
Table North America Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Influenza Vaccine Revenue Market Share by Countries
Figure United States Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Influenza Vaccine Sales by Product (2014-2019) (K Units)
Table North America Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Influenza Vaccine Market Share by Product
Table North America Influenza Vaccine Sales by End User (2014-2019) (K Units)
Table North America Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Influenza Vaccine Market Share by End User
Figure Europe Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Influenza Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Influenza Vaccine Sales Market Share by Countries
Table Europe Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Influenza Vaccine Revenue Market Share by Countries
Figure Germany Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Influenza Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Influenza Vaccine Market Share by Product
Table Europe Influenza Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Influenza Vaccine Market Share by End User
Figure Asia Pacific Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Influenza Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccine Sales Market Share by Countries
Table Asia Pacific Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccine Revenue Market Share by Countries
Figure China Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Influenza Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccine Market Share by Product
Table Asia Pacific Influenza Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Influenza Vaccine Market Share by End User
Figure Central & South America Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Influenza Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Influenza Vaccine Sales Market Share by Countries
Table Central & South America Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Influenza Vaccine Revenue Market Share by Countries
Figure Brazil Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Influenza Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Influenza Vaccine Market Share by Product
Table Central & South America Influenza Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Influenza Vaccine Market Share by End User
Figure Middle East and Africa Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Influenza Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccine Sales Market Share by Countries
Table Middle East and Africa Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccine Revenue Market Share by Countries
Figure GCC Countries Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Influenza Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccine Market Share by Product
Table Middle East and Africa Influenza Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Influenza Vaccine Market Share by End User
Table AstraZeneca Company Details
Table AstraZeneca Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table CSL Company Details
Table CSL Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Altimmune Company Details
Table Altimmune Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Altimmune Recent Development
Table BionVax Company Details
Table BionVax Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BionVax Recent Development
Table FluGen Company Details
Table FluGen Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table FluGen Recent Development
Table Folia Biotech Company Details
Table Folia Biotech Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Folia Biotech Recent Development
Table Genentech Company Details
Table Genentech Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech Recent Development
Table Green Cross Company Details
Table Green Cross Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Green Cross Recent Development
Table Medicago Company Details
Table Moderna Therapeutics Company Details
Table Novavax Company Details
Table Shijiazhuang Yiling Pharmaceutical Company Details
Table SK Chemicals Company Details
Table UNM Pharma Company Details
Table Vaccitec Company Details
Table Global Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Influenza Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Influenza Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Influenza Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Influenza Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Influenza Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Influenza Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Influenza Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Influenza Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Influenza Vaccine Value Chain
Table Influenza Vaccine Customers List
Table Influenza Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Meningococcal Conjugate Market Size, Status and Forecast 2019-2025
    Published: 24-Jun-2019        Price: US 3900 Onwards        Pages: 91
    Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. In 2018, the global Meningococcal Conjugate market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.......
  • Encephalitis Vaccination Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
    Published: 23-Jun-2019        Price: US 2280 Onwards        Pages: 54
    According to 99Strategy, the Global Encephalitis Vaccination Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Encephalitis Vaccination market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the f......
  • Encephalitis Vaccination Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 18-Jun-2019        Price: US 3000 Onwards        Pages: 138
    Encephalitis Vaccination Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Encephalitis Vaccination industry with a focus on the Chinese market. The report provides key statistics on the market status of the Encephalitis Vaccination manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and......
  • Global Encephalitis Vaccination Market Research Report 2012-2024
    Published: 17-Jun-2019        Price: US 1800 Onwards        Pages: 69
    Summary The global Encephalitis Vaccination market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentione......
  • HaemophilB Conjugate Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 17-Jun-2019        Price: US 3000 Onwards        Pages: 143
    HaemophilB Conjugate Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global HaemophilB Conjugate Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the HaemophilB Conjugate Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-202......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2012-2024
    Published: 17-Jun-2019        Price: US 1800 Onwards        Pages: 69
    Summary The global 23-Valent Pneumococcal Polysaccharide Vaccine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional mark......
  • Meningococcal Conjugate Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 16-Jun-2019        Price: US 3000 Onwards        Pages: 148
    Meningococcal Conjugate Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Meningococcal Conjugate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Meningococcal Conjugate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Ch......
  • Global Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2025
    Published: 14-Jun-2019        Price: US 3900 Onwards        Pages: 112
    Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age. The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.  The global Pneumococcal Po......
  • Influenza Vaccine Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
    Published: 13-Jun-2019        Price: US 2280 Onwards        Pages: 58
    According to 99Strategy, the Global Influenza Vaccine Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Influenza Vaccine market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs